PMDA drug package insert
塩酸「タイセイ」
PMDA Prescription drug · 大成薬品工業株式会社 · package insert Aug 28, 2023
Key facts
| Brand names | 塩酸「タイセイ」 |
|---|---|
| Nonproprietary names | 塩酸 |
| Companies | 製造販売元／大成薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 調剤用薬 |
| Therapeutic category codes | 87719 |
| YJ codes | 7190702X1065 |
| Approval numbers | 16000AMZ06570 |
| Package insert date | Aug 28, 2023 |
| PMDA document key | 400069_7190702X1065_1 |
| PMDA company code | 400069 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: